Literature DB >> 31863869

Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases.

Nikolina Maček Hrvat1, Jarosław Kalisiak2, Goran Šinko1, Zoran Radić3, K Barry Sharpless2, Palmer Taylor3, Zrinka Kovarik4.   

Abstract

Acetylcholinesterase (AChE) is a pivotal enzyme in neurotransmission. Its inhibition leads to cholinergic crises and could ultimately result in death. A related enzyme, butyrylcholinesterase (BChE), may act in the CNS as a co-regulator in terminating nerve impulses and is a natural plasma scavenger upon exposure to organophosphate (OP) nerve agents that irreversibly inhibit both enzymes. With the aim of improving reactivation of cholinesterases phosphylated by nerve agents sarin, VX, cyclosarin, and tabun, ten phenyltetrahydroisoquinoline (PIQ) aldoximes were synthesized by Huisgen 1,3 dipolar cycloaddition between alkyne- and azide-building blocks. The PIQ moiety may serve as a peripheral site anchor positioning the aldoxime moiety at the AChE active site. In terms of evaluated dissociation inhibition constants, the aldoximes could be characterized as high-affinity ligands. Nevertheless, high binding affinity of these oximes to AChE or its phosphylated conjugates did not assure rapid and selective AChE reactivation. Rather, potential reactivators of phosphylated BChE, with its enlarged acyl pocket, were identified, especially in case of cyclosarin, where the reactivation rates of the lead reactivator was 100- and 6-times that of 2-PAM and HI-6, respectively. Nevertheless, the return of the enzyme activity was affected by the nerve agent conjugated to catalytic serine, which highlights the lack of the universality of reactivators with respect to both the target enzyme and OP structure.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acetylcholinesterase; Antidote; Butyrylcholinesterase; Nerve agent; Organophosphate; Peripheral anionic site; Pralidoxime

Mesh:

Substances:

Year:  2019        PMID: 31863869      PMCID: PMC7053431          DOI: 10.1016/j.toxlet.2019.12.016

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  58 in total

1.  Novichok: a murderous nerve agent attack in the UK.

Authors:  J Allister Vale; Timothy C Marrs; Robert L Maynard
Journal:  Clin Toxicol (Phila)       Date:  2018-05-14       Impact factor: 4.467

2.  Acetylcholinesterase: converting a vulnerable target to a template for antidotes and detection of inhibitor exposure.

Authors:  Palmer Taylor; Zrinka Kovarik; Elsa Reiner; Zoran Radić
Journal:  Toxicology       Date:  2006-11-24       Impact factor: 4.221

3.  Post-exposure treatment with the oxime RS194B rapidly reverses early and advanced symptoms in macaques exposed to sarin vapor.

Authors:  Yvonne J Rosenberg; Lingjun Mao; Xiaoming Jiang; Jonathan Lees; Limin Zhang; Zoran Radic; Palmer Taylor
Journal:  Chem Biol Interact       Date:  2017-07-08       Impact factor: 5.192

4.  Potent 3-Hydroxy-2-Pyridine Aldoxime Reactivators of Organophosphate-Inhibited Cholinesterases with Predicted Blood-Brain Barrier Penetration.

Authors:  Tamara Zorbaz; Anissa Braïki; Nikola Maraković; Julien Renou; Eugenio de la Mora; Nikolina Maček Hrvat; Maja Katalinić; Israel Silman; Joel L Sussman; Guillaume Mercey; Catherine Gomez; Romain Mougeot; Belén Pérez; Rachid Baati; Florian Nachon; Martin Weik; Ludovic Jean; Zrinka Kovarik; Pierre-Yves Renard
Journal:  Chemistry       Date:  2018-06-08       Impact factor: 5.236

5.  New structural scaffolds for centrally acting oxime reactivators of phosphylated cholinesterases.

Authors:  Rakesh K Sit; Zoran Radić; Valeria Gerardi; Limin Zhang; Edzna Garcia; Maja Katalinić; Gabriel Amitai; Zrinka Kovarik; Valery V Fokin; K Barry Sharpless; Palmer Taylor
Journal:  J Biol Chem       Date:  2011-04-04       Impact factor: 5.157

6.  Kinetic analysis of interactions between alkylene-linked bis-pyridiniumaldoximes and human acetylcholinesterases inhibited by various organophosphorus compounds.

Authors:  Timo Wille; Fredrik Ekström; Jong-Cheol Lee; Yuan-Ping Pang; Horst Thiermann; Franz Worek
Journal:  Biochem Pharmacol       Date:  2010-05-26       Impact factor: 5.858

7.  Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates.

Authors:  F Worek; G Reiter; P Eyer; L Szinicz
Journal:  Arch Toxicol       Date:  2002-07-12       Impact factor: 5.153

8.  Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization.

Authors:  L Raveh; J Grunwald; D Marcus; Y Papier; E Cohen; Y Ashani
Journal:  Biochem Pharmacol       Date:  1993-06-22       Impact factor: 5.858

9.  Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.

Authors:  Anita Bosak; Ivana Gazić; Vladimir Vinković; Zrinka Kovarik
Journal:  Arch Biochem Biophys       Date:  2007-12-23       Impact factor: 4.013

10.  Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates.

Authors:  Zrinka Kovarik; Zoran Radić; Harvey A Berman; Vera Simeon-Rudolf; Elsa Reiner; Palmer Taylor
Journal:  Biochemistry       Date:  2004-03-23       Impact factor: 3.162

View more
  4 in total

1.  Use of connectivity index and simple topological parameters for estimating the inhibition potency of acetylcholinesterase.

Authors:  Ante Miličević; Goran Šinko
Journal:  Saudi Pharm J       Date:  2022-02-08       Impact factor: 4.562

2.  Kinetic Processes in Enzymatic Nanoreactors for In Vivo Detoxification.

Authors:  Zukhra Shajhutdinova; Tatiana Pashirova; Patrick Masson
Journal:  Biomedicines       Date:  2022-03-27

Review 3.  Counteracting poisoning with chemical warfare nerve agents.

Authors:  Nikolina Maček Hrvat; Zrinka Kovarik
Journal:  Arh Hig Rada Toksikol       Date:  2020-12-31       Impact factor: 2.078

4.  Assessment of four organophosphorus pesticides as inhibitors of human acetylcholinesterase and butyrylcholinesterase.

Authors:  Tena Čadež; Dora Kolić; Goran Šinko; Zrinka Kovarik
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.